PAULDING MEDICAL CENTER — History
CCN 110042 | 3-year financial timeline | COVID resilience: 44/100
🛡️ Public data only — no PHI permitted on this instance.
$289M
Latest Revenue (FY2022)
+7.8%
Revenue CAGR (3yr)
9.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $248M | $258M | $289M | +11.9% | +7.8% |
| Operating Expenses | $202M | $237M | $263M | +10.9% | +14.0% |
| Operating Margin | 18.5% | 8.2% | 9.0% | +9.7% | -30.4% |
| Net Income | $46M | $21M | $26M | +22.8% | -24.9% |
| Licensed Beds | 112 | 112 | 112 | +0.0% | +0.0% |
| Total Patient Days | 35,913 | 37,874 | 37,119 | -2.0% | +1.7% |
| Medicare Day % | 31% | 28% | 30% | +5.7% | -1.5% |
| Medicaid Day % | 7% | 6% | 5% | -7.1% | -11.2% |
COVID Impact & Recovery
Resilience Score: 44/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +16.3% ($248M → $289M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.8%
This Hospital
+7.6%
State Avg
Latest Margin
9.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $309M | 4.2% |
| FY2024 (proj) | $329M | -0.6% |
| FY2025 (proj) | $349M | -5.3% |